Request Offer

Immutep Limited

  • Immutep is a biotechnology company developing immunotherapeutic products targeting the LAG-3 immune checkpoint for the treatment of cancer and autoimmune diseases.
  • Immutep has collaborations with four of the world’s top 10 pharmaceutical companies and is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP).